Cangrelor intermediate 10596-23-3
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Brand name
- Bocimed
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- api, pharmaceutical, pharmaceutical intermediates, cangrelor
- Category
- Pharmaceutical Intermediates
Shanghai Bocimed Pharmaceutical Co., Ltd.
China
- Verified Certificate
-
7
| Product name | Cangrelor intermediate 10596-23-3 | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | api , pharmaceutical , pharmaceutical intermediates , cangrelor | Unit Size | - |
| Brand name | Bocimed | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
We manufacture and provide Cangrelor intermediate with commercial capability
CAS 10596-23-3
Purity is ≥９８％
Cangrelor:
Cangrelor is clinically well tolerated and safe and has no drug-drug interaction with aspirin, heparin or nitroglycerin. Unlike orally dosed thienopyridines, cangrelor can be administered intravenously and binds directly to P2Y12 receptor sites of platelets.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ms. Ying
- Address
- Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
- Product Category
- Organic Intermediate
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
Shanghai Bocimed Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in drug research and development technical services, one of Shanghai high-tech enterprises, Shanghai integrity created enterprise, Shanghai SME innovation enterprises. The company started in 2007, formerly known as Shanghai MABCT Medicine Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in sales of raw materials, the drug import registration and China regional cooperation development.
Bocimed is focus on the R&D and manufacture of pharmaceutical API and intermediates, has the R&D center in Shanghai with more than 2500m2, and the factory is located in Gansu Province, China.
- Main Product
Related Products
Cas 24131-07-5
beta-cyclodextrin
Betamethasone 17-valerate
Water Soluble Chitosan
120/80 SYMBIOSAL _ antihypertensive salt
